Patterson Companies Inc
F:PD2

Watchlist Manager
Patterson Companies Inc Logo
Patterson Companies Inc
F:PD2
Watchlist
Price: 27.4 EUR
Market Cap: €2.4B

P/E

20
Current
48%
More Expensive
vs 3-y average of 13.5

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
20
=
Market Cap
€2.8B
/
Net Income
$138.8m

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
20
=
Market Cap
€2.8B
/
Net Income
$138.8m

Valuation Scenarios

Patterson Companies Inc is trading above its 3-year average

If P/E returns to its 3-Year Average (13.5), the stock would be worth €18.57 (32% downside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-32%
Maximum Upside
+38%
Average Downside
2%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 20 €27.4
0%
3-Year Average 13.5 €18.57
-32%
5-Year Average 13.9 €19.13
-30%
Industry Average 27.6 €37.86
+38%
Country Average 22.9 €31.38
+15%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
€2.8B
/
Jan 2025
$138.8m
=
20
Current
€2.8B
/
Apr 2025
$192.5m
=
14.4
Forward
€2.8B
/
Apr 2026
$210.9m
=
13.1
Forward
€2.8B
/
Apr 2027
$227.9m
=
12.2
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Market Distribution

In line with most companies in the United States of America
Percentile
37th
Based on 8 489 companies
37th percentile
17.5
Low
0 — 15.3
Typical Range
15.3 — 33.2
High
33.2 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 15.3
Median 22.9
70th Percentile 33.2
Max 1 826 183.3

Patterson Companies Inc
Glance View

Market Cap
2.4B EUR
Industry
Health Care

Patterson Companies Inc., a prominent player in the healthcare distribution sector, has carved its niche by focusing on two essential markets: dental and animal health. Established in the late 19th century, Patterson began as a humble supplier of dental products, and over the decades, it expanded its portfolio to meet the growing demands of an ever-evolving healthcare landscape. This expansion is exemplified in its strategic shift towards animal health, a sector that has burgeoned with rising global pet ownership and increased attention to veterinary care. Through its extensive network, Patterson supplies everything from dental chairs and compressors to veterinarians' pharmaceuticals and surgical equipment, ensuring practitioners are well-equipped to meet their patients' needs. Much of Patterson's success can be attributed to its diversified distribution model and its focus on building strong relationships with manufacturers and healthcare providers. Operating in the highly competitive distribution industry, Patterson generates revenue by acting as a bridge between manufacturers and a wide-reaching customer base. This involves not just logistical expertise to get products where they need to be, but also offering value-added services such as training, integrated technology solutions, and business consulting to its clients. By embedding itself deeper into its clients' operational ecosystems, Patterson ensures customer loyalty and positions itself as more than just a supplier, but a crucial partner in healthcare outcomes.

PD2 Intrinsic Value
42.29 EUR
Undervaluation 35%
Intrinsic Value
Price €27.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett